Testing the Validity of Cost-Effectiveness Models
- 1 May 2000
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 17 (5) , 501-513
- https://doi.org/10.2165/00019053-200017050-00007
Abstract
A growing body of recent work has identified several problems with economic evaluations undertaken alongside controlled trials that can have potentially serious impacts on the ability of decision...Keywords
This publication has 29 references indexed in Scilit:
- Valuing Health-Related Quality of LifePharmacoEconomics, 1999
- The Use of QALY and Non-QALY Measures of Health-Related Quality of LifePharmacoEconomics, 1998
- The Selection of Data Sources For Use in Modelling StudiesPharmacoEconomics, 1998
- Exorcising Protocol-induced Spirits:Medical Decision Making, 1997
- A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical TrialsPharmacoEconomics, 1996
- Can Resource Use be Extracted from Randomized Controlled Trials to Calculate Costs?: A Review of Smoking Cessation Interventions in General PracticeInternational Journal of Technology Assessment in Health Care, 1996
- The Journal's Policy on Cost-Effectiveness AnalysesNew England Journal of Medicine, 1994
- Economic evaluation alongside cancer trials: Methodological and practical aspectsEuropean Journal Of Cancer, 1993
- Economic evaluation and quality of life assessments in cancer clinical trials: The CHART trialEuropean Journal Of Cancer, 1993
- Economic Analysis in Randomized Control TrialsMedical Care, 1992